Leiodelide A, which was isolated from
Leiodermatium sponges in 2006, showed significant cytotoxicity in the National
Cancer Institute’s 60 cell line panel with enhanced activity against HL-60
leukemia and OVCAR-3 ovarian cancer cell lines. The goal of this project is
to achieve an efficient and enantioselective synthesis of Leiodelide A through
the use of new silane reagents. This total synthesis will
provide a highly convergent synthetic route and will allow for the
determination of its absolute stereochemistry of the molecule.